Navigation Links
AACR recognizes the outstanding achievements of Pier Paolo Pandolfi

ORLANDO, Fla. Pier Paolo Pandolfi, M.D., Ph.D., is the recipient of the 2011 Pezcoller Foundation-AACR International Award for Cancer Research for his outstanding work in the field of cancer genetics and mouse models for cancer. This work has contributed to new therapies for treating cancers.

"Dr. Pandolfi's research has had a profound impact on our understanding of the molecular underpinnings of acute promyelocytic leukemia (APL)," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. "His laboratory's mouse models for various subtypes of APL have shown efficacy when utilizing different drug combinations. Clearly, this innovative research is leading to progress in the treatment of other types of cancer."

Pandolfi is the George C. Reisman Professor of Medicine and a professor of pathology at Harvard Medical School; director of research at the Beth Israel Deaconess Cancer Center; and director of the cancer genetics program and chief of the division of genetics in the department of medicine at the Beth Israel Deaconess Medical Center. His studies have had an impact on the cancer research arena by broadening the understanding of the molecular basis of cancer.

The research carried out in Pandolfi's laboratory has been important in understanding the molecular mechanisms and genetics underlying the pathogenesis of leukemias, lymphomas and solid tumors, as well as in modeling these cancers in mice.

Among his many accomplishments, Pandolfi and colleagues have characterized the function of oncoproteins and genes involved in the chromosomal translocations of APL, as well as of major tumor suppressors such as PTEN and p53, and novel proto-oncogenes, such as POKEMON. These accomplishments have led to the development of novel and effective therapeutic strategies, and, as a result, APL is now considered a curable disease.

Additional novel therapeutic concepts have emerged from Pandolfi's research, which are currently being tested in clinical trials. More recently, Pandolfi and colleagues have presented a new theory describing how mRNA, both coding and non-coding, exerts biological functions with profound implications for human genetics, cell biology and cancer biology.

Pandolfi received his medical degree in 1989 and his doctorate in 1996 from the University of Perugia in Italy, after he studied philosophy at the University of Rome. He received post-graduate training at the National Institute for Medical Research and the University of London in the United Kingdom.

In 1994, Pandolfi became an assistant member of the molecular biology program and the department of human genetics at Memorial Sloan-Kettering Cancer Center. He grew through the ranks to become a member in the cancer biology and genetics program at the Sloan-Kettering Institute; professor of molecular biology and human genetics, and professor of molecular biology in pathology and laboratory medicine at the Weill Graduate School of Medical Sciences at Cornell University; and head of the molecular and developmental biology laboratories, and the incumbent of the Albert C. Foster Endowed Chair for Cancer Research at Memorial Sloan-Kettering Cancer Center.

Among his lauded career experiences, Pandolfi has also received numerous awards including: the LLSA Scholar Award (1997); the Irma T. Hirschl Trust Award (1999); the Alexandra J. Kefalides Prize for Leukemia Research (1999); the Hamdan Award for Medical Research Excellence (2000); the Lombroso Prize for Cancer Research of the Weizmann Institute of Science (2001); the Leukemia and Lymphoma Society's Stohlman Scholar Award (2001); the William and Linda Steere Foundation Award (2004); and, the prize for Scientific Excellence in Medicine from the American-Italian Cancer Foundation (2005).

He also has been awarded the National Institutes of Health MERIT Award, the Fondazione Cortese International Award, the Prostate Cancer Foundation Creativity Award and the Ischia International Award. In 2006, Pandolfi was elected as a member of the American Society for Clinical Investigation and the American Association of Physicians, and the following year he became a member of the European Molecular Biology Organization.

The Pezcoller Foundation-AACR International Award, now in its 14th year, recognizes an individual scientist of international renown who has made a major scientific discovery in basic or translational cancer research.

Pandolfi will give an award lecture during the AACR 102nd Annual Meeting 2011, on Monday April 4 at 5 p.m. ET in the Orange County Convention Center, Orlando, Fla.


Contact: Michele Sharp
American Association for Cancer Research

Related medicine news :

1. ASGE recognizes 35 endoscopy units for quality and safety as part of its Endoscopy Unit Recognition Program
2. EMBO recognizes 63 researchers for advances in life sciences
3. ASGE recognizes 48 endoscopy units for quality as part of its Endoscopy Unit Recognition Program
4. The John Theurer Cancer Center recognizes medical physics team for safety track record
5. Child Life Council Recognizes Leaders in Child Life for Distinguished Service, Clinical Excellence and Philanthropic Support at 28th Annual Conference
6. Recognizes Two RMACT Fertility Doctors as 'Leading On-Time Doctors'
7. Verdict Search recognizes Applied Forensics in Top 25 New York Verdicts of 2009
8. American Brain Tumor Association Recognizes Philadelphia Family Foundation With Annual Award
9. Georgia Kidney Community Recognizes World Kidney Day; Echoes Need for Legislation to Improve Access to Dialysis and Transplant Care
10. Department of Public Welfare Recognizes Contributions of Pennsylvanians with Developmental Disabilities
11. DAV Recognizes President for Supporting Veterans Health Care Budget Reform
Post Your Comments:
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... ... to fertility once they have been diagnosed with endometriosis. These women need a ... they also require a comprehensive approach that can help for preservation of fertility ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 VolitionRx ... of Dr. Edward Futcher to the ... effective June 23, 2016.Dr. Futcher was also appointed ... Governance Committees.  As a non-executive member of the ... and strategic counsel to VolitionRx in connection with ...
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
Breaking Medicine Technology: